Shares in Bruker BioSciences gained 11.4 percent over the past three weeks, leading the 11 firms whose shares rose during the three-week trading period ended Tuesday (Note: BioCommerce Week did not publish the past two weeks). Bio-Rad posted the next-largest increase with a gain of 6.8 percent.
Stratagene slumped again to a new 52-week low to close at $4.70 on Tuesday, down 14.4 percent for the three-week period.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.